Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3423- Is this information wrong?
Summary
- Dr. Saby George is an oncologist in Buffalo, NY and is affiliated with multiple hospitals in the area, including Cleveland Clinic, Miami Valley Hospital, and Roswell Park Comprehensive Cancer Center. He received his medical degree from Kottayam Medical College and has been in practice 18 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in Urologic oncology with a particular research focus on Kidney cancer, prostate cancer, and bladder cancer.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
Cleveland Clinic FoundationFellowship, Experimental Therapeutics In Medical Oncology, 2006 - 2008
Wright State UniversityResidency, Internal Medicine, 2003 - 2006
Kottayam Medical CollegeClass of 1999
Certifications & Licensure
OH State Medical License 2003 - 2025
NY State Medical License 2010 - 2025- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer Start of enrollment: 2006 Oct 01
- Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Oct 29
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2010 Feb 06
- Join now to see all
Publications & Presentations
PubMed
- Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo, Andrea Harzstark, Channing J Paller, Saby George, Matthew R Zibelman, Heather ...> ;European Urology Oncology. 2024 Mar 23
- Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (...Dizdarevic, S., Logue, J., de Jong, I., Tomaszewski, J., Saad, F., Miller, K., Meltzer, J., Sandström, P., Verholen, F., Tombal, B., Sartor, O., Higano, C., Richardson...> ;Cancer. 2024 Feb 10
- NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Hilary Bagshaw, Michael Baine, Kathryn Beckermann, Maria I Carlo, Toni K Choueiri, Brian A Costello, Ithaar ...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
- Join now to see all
Press Mentions
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023- New Insights on Sarcomatoid Kidney Cancer: Roswell Park Reports Clear Benefit from Checkpoint InhibitorsJune 9th, 2021
- Roswell Park Researchers Gear up for ASCO 2021 Annual MeetingJune 3rd, 2021
- Join now to see all
Hospital Affiliations
Roswell Park Comprehensive Cancer CenterBuffalo, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
